In the current study, the TAA panel for detecting anti-TAAs antibodies in PCa has been improved by a mini-array of seven TAAs including cyclin B1, survivin, p53, RalA, DFS70/LEDGFp75, MDM2, and NPM1. This evidence concerns the gene NPM1 and posterior cortical atrophy.